NCT07025798

Brief Summary

The primary objective of this study is to evaluate the effects of the compound probiotic freeze-dried powder on gastrointestinal function and its impact on gut microbiota, immune factors, inflammatory markers, and intestinal barrier function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 30, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 12, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

June 16, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 18, 2025

Completed
Last Updated

June 18, 2025

Status Verified

June 1, 2025

Enrollment Period

9 months

First QC Date

June 16, 2025

Last Update Submit

June 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improvement of gastrointestinal symptoms

    Bowel movement frequency improvement: use the "bowel movement frequency scale"

    4 weeks

Study Arms (2)

Wec120B group

EXPERIMENTAL
Dietary Supplement: Probiotic

Wec300B group

EXPERIMENTAL
Dietary Supplement: Probiotic

Interventions

ProbioticDIETARY_SUPPLEMENT

Probiotic strips with different strain formulas, Specification: 2g/bag. Storage method: Keep away from light, seal tightly, and store in a cool, dry place.

Wec120B groupWec300B group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • (1)Age: 18-65; (2)It conforms to the diagnostic criteria for gastrointestinal dysfunction formulated in the "Expert Consensus on Precision Health Communication in China - Guidelines for Citizens' Intestinal Health"; (3)Symptoms: Irregular defecation, loose or hard stools; Intestinal rumbling in the abdomen Abdominal distension Hiccups, belching; Severe intestinal flatulence; Abdominal pain Acid reflux and heartburn; Pain in the stomach or abdomen when hungry; Disgusting; (4) Signs: Abdominal pain and abdominal distension; Diarrhea and constipation Indigestion Gastric acid reflux Bad breath and farting smell; Skin problems The color and shape of the stool have changed.

You may not qualify if:

  • (1)Drugs that affect the intestinal flora (including antibacterial drugs, microecological preparations, intestinal mucosal protectants, traditional Chinese patent medicines, etc.) should be used continuously for more than one week within one month before screening; (2)Recent use of products with similar functions to the test product, which may interfere with the judgment of the study results; (3) use of antibiotics during illness; (3)Use of antibiotics during illness; (4)Resence of severe systemic diseases or malignant tumors; (5)allergy to any components of the probiotics used in the study; (6)women who are pregnant, breastfeeding, or planning to conceive in the near future.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Food and Bioengineering, Henan University of Science and Technology

Luoyang, Henan, 471000, China

Location

MeSH Terms

Interventions

Probiotics

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2025

First Posted

June 18, 2025

Study Start

August 30, 2024

Primary Completion

June 10, 2025

Study Completion

June 12, 2025

Last Updated

June 18, 2025

Record last verified: 2025-06

Locations